New Jersey
LocationRelationship Network
HOUSE_OVERSIGHT_024725.jpg
This document is page 89 of a 2017 report by Ackrell Capital regarding the U.S. legal landscape for cannabis. It predicts legislative changes in 2018 for various states and analyzes the timeline for federal legalization based on public support data from Gallup. The document bears a 'HOUSE_OVERSIGHT_024725' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though the content itself is a general market analysis rather than specific correspondence.
HOUSE_OVERSIGHT_024699.jpg
This document is a page from an Ackrell Capital report (Chapter IV: U.S. Legal Landscape) featuring a map and list of U.S. state cannabis laws as of January 2018. It categorizes states by Recreational Law, Medical Cannabis Law, CBD/Limited Law, or No Law. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production to Congress (potentially related to financial investigations involving Epstein or related banks), the content itself is purely market research regarding the cannabis industry and contains no specific mention of Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_024644.jpg
This document is page 8 of a December 2017 Cannabis Investment Report by Ackrell Capital, LLC. It analyzes the growth of the legal cannabis markets in California and Canada, predicting significant expansion in 2018 due to legislative changes like the Cannabis Act. The report also discusses the evolution of consumer products towards 'mainstream' acceptance, highlighting innovations in product types (concentrates, infused products) and the increasing sophistication of dispensaries and branding.
HOUSE_OVERSIGHT_013872.jpg
This document appears to be a page from a magazine article (likely by A.J. Jacobs for Esquire) included in a House Oversight Committee document dump (stamped HOUSE_OVERSIGHT_013872). The text details the author's experience outsourcing his personal life to virtual assistants in Bangalore, specifically naming two assistants, Honey and Asha. It features a humorous anecdote where Honey writes an overly polite rejection email to the Colorado Tourism Board on the author's behalf.
HOUSE_OVERSIGHT_025542.jpg
This document is a first-person statement, likely by Jeffrey Epstein, criticizing the handling of his plea deal and subsequent civil suits. He alleges that the government violated the spirit of his agreement, that an opposing attorney engaged in nepotism and excessive billing ($800,000), and that the accusers were unreliable witnesses who worked in the sex trade. He defends himself by claiming he was merely a 'consumer of prostitution' rather than a trafficker and explains he took the plea deal to avoid a mandatory 10-year sentence and a biased trial.
HOUSE_OVERSIGHT_025304.jpg
This document is a political analysis report produced by Laffer Associates, dated July 6, 2016. It presents statistical tables comparing Republican and Democrat voter turnout in various state primaries and caucuses between 2008, 2012, and 2016. The analysis concludes that the data should be concerning for Hillary Clinton's presidential campaign. The document bears a House Oversight Committee stamp, suggesting it was part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_024815.jpg
This document is a page from an Ackrell Capital report listing the 'Top 100 Private Cannabis Companies 2018'. It contains a categorized list of 100 entities in the cannabis industry, a standard investment disclaimer footer, and a Bates stamp indicating it is part of a House Oversight Committee investigation (HOUSE_OVERSIGHT_024815). No specific individuals, aircraft, or direct communications are listed on this page.
HOUSE_OVERSIGHT_024774.jpg
This document is page 138 from a December 2017 Cannabis Investment Report produced by Ackrell Capital. It lists the 'Top 100 Private Cannabis Companies' for 2018, categorized alphabetically across four columns. The document bears a 'HOUSE_OVERSIGHT_024774' stamp, indicating it is part of a House Oversight Committee investigation file.
HOUSE_OVERSIGHT_029915.jpg
This document is an email chain from late 2010 between Michael Greenberg and Benjamin Wegg-Prosser. They discuss business opportunities involving 'FIO' and investments in Russia, specifically mentioning Rusnano and Mikhail Prokhorov's Onexim Group. Greenberg also explicitly requests Lord Mandelson's correct email address, noting that previous attempts to contact him had failed.
HOUSE_OVERSIGHT_029512.jpg
The narrator recounts their immigration from India to the United States to pursue a medical career, detailing their residency in New Jersey and Boston. They describe entering the field of neuroendocrinology, training under Seymour Reichlin at Tufts, and meeting Candace Pert, who introduced them to the concept of "molecules of emotion."
HOUSE_OVERSIGHT_014079.jpg
This document appears to be page 100 of a legal review article authored by Paul Cassell (a lawyer for Epstein's victims), submitted as evidence to the House Oversight Committee. The text analyzes state laws (CO, MO, NJ, MA, ID) that extend victims' rights to the pre-charge stage and require prosecutor consultation regarding plea agreements. This legal argument is central to the Epstein case controversy, specifically regarding the secret Non-Prosecution Agreement signed before federal charges were filed.
HOUSE_OVERSIGHT_021017.jpg
This document contains two slides from a KPCB presentation (likely Mary Meeker's 'USA Inc.' report) analyzing government efficiency and cost-cutting measures through outsourcing and automation. It presents financial data spanning 1993-2010, detailing specific savings achieved by state governments (MO, PA, FL, TX) and organizations like the Red Cross and Port Authority of NY/NJ. The document bears a 'HOUSE_OVERSIGHT_021017' Bates stamp, suggesting it was part of a production to the House Oversight Committee.
HOUSE_OVERSIGHT_014204.jpg
This document is page 78 from an address book (likely the 'Epstein Black Book') containing contact details for various individuals. Key entries include Darren K. Indyke (Epstein's lawyer) with extensive contact details including a 'New House' date of 8/19/2003, Joey Hunter (Director of Modelwire), and Svetlana Griaznova (model). The page lists addresses in New York, New Jersey, Washington D.C., and London, along with phone numbers and email addresses.
HOUSE_OVERSIGHT_032324.jpg
This document is a data analysis report titled 'US Election Report' bearing a House Oversight stamp. It details sentiment analysis derived from approximately 3 million tweets collected from November 1st (presumably 2016), comparing Donald Trump and Hillary Clinton. It provides positive/neutral/negative sentiment percentages, overall winning chances favoring Trump (55%), and a breakdown of projected polling or winning chances across various specific US states.
HOUSE_OVERSIGHT_024443.jpg
This document is page 10 of a legal offering memorandum (marked with House Oversight Bates stamp 024443). It contains regulatory disclaimers and notices for investors residing in Italy, Japan, Jersey, Kuwait, and Mexico regarding the private offering of securities ('Units'). It specifies that the offering has not been registered with local authorities in these jurisdictions and is intended for institutional or qualified investors.
HOUSE_OVERSIGHT_016381.jpg
This document appears to be a page from a report or academic text included in House Oversight files. It details the work of Anne Milgram (former NJ Attorney General and VP at the Arnold Foundation) regarding the implementation of data analytics and algorithms in criminal justice to create objective risk assessments. The text also philosophically discusses the history and nature of 'scientific objectivity' versus subjective decision-making.
HOUSE_OVERSIGHT_028422.jpg
This document, labeled HOUSE_OVERSIGHT_028422, is a JSON data file containing metadata for several New York Times articles delivered via Apple News. The content, primarily dated September 24, 2018, concerns the 2018 New Jersey Senate race between Robert Menendez and former Celgene executive Bob Hugin. It also references a related article about Celgene settling a $280 million fraud lawsuit in 2017.
HOUSE_OVERSIGHT_028420.jpg
The document is JSON code describing an article about the pharmaceutical company Celgene. The article alleges that Celgene used a federal safety program (REMS) to block generic competition for its drugs, Revlimid and Thalomid, leading to lawsuits from companies like Mylan. The text also mentions a patient paying high costs and a professor criticizing Celgene's actions.
HOUSE_OVERSIGHT_028417.jpg
This document is a data extract, likely from a news article, which has been marked as an exhibit for a House Oversight investigation. The text details the history of the pharmaceutical company Celgene and its drug Thalomid (thalidomide), including its approval by the F.D.A. in 1998 and the context of executive Bob Hugin's subsequent political career. The document contains no information related to Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_028416.jpg
This document is an excerpt from an article detailing controversies surrounding pharmaceutical executive Mr. Hugin, a former CEO of Celgene. It highlights Celgene's aggressive drug promotion, a $280 million settlement for illegal marketing, and accusations of fighting generic competition. The text notes that these issues, particularly rising drug costs, are being used against Hugin in a political campaign by his opponent, Mr. Menendez.
HOUSE_OVERSIGHT_028415.jpg
This document is a web article discussing the 2018 U.S. Senate campaign of Bob Hugin in New Jersey. It details his professional background as a former executive at the pharmaceutical company Celgene, presenting it as both a cornerstone of his campaign and a potential liability due to public anger over high drug prices. Although the prompt described it as 'Epstein-related,' the content of this specific document, labeled 'HOUSE_OVERSIGHT_028415,' does not mention Jeffrey Epstein or any related matters.
HOUSE_OVERSIGHT_028414.jpg
This document is the underlying data file for a New York Times article published on September 24, 2018, about G.O.P. Senate candidate Bob Hugin's career at the pharmaceutical company Celgene. The document, labeled 'HOUSE_OVERSIGHT_028414', includes a photo caption from a 2014 Celgene event in Summit, N.J., attended by Hugin, Representative Leonard Lance, and former Governor Chris Christie. The content of this specific document does not contain any mention of Jeffrey Epstein.
HOUSE_OVERSIGHT_026392.jpg
This document is the final page of a civil complaint (Case 1:16-cv-04642), filed on June 20, 2016. The plaintiff, represented by attorney Thomas Francis Meagher, requests that the court issue an order of protection against the defendants and demands a trial by jury. The document provides the attorney's contact information in Princeton, New Jersey.
HOUSE_OVERSIGHT_022377.jpg
This document, produced by EY following the 2016 election, provides a profile of expected US Senate committee leadership for the upcoming Congress. It details the chairmen and ranking members for key committees and analyzes the various political scenarios influencing these appointments, such as retirements, term limits, and senators' strategic choices. Despite the prompt's framing, the document's content is purely about US Senate politics and contains no information related to Jeffrey Epstein.
HOUSE_OVERSIGHT_022348.jpg
This document is a chain of forwarded emails from February 29 to March 1, 2012, culminating in an email sent from Darren Indyke to Jeffrey Epstein. The email, marked with "High" importance, circulates a link to a Fox News article concerning an 'Obama-bundler' who works as a tax adviser in the Virgin Islands. The email chain originates from Justin Blackhall, a counsel at OlenderFeldman LLP, and is passed through several individuals before reaching Epstein, suggesting a network of associates sharing potentially relevant news.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity